{"schema_version":"secwatch.filing_event.v1","accession":"0001477932-23-006695","form_type":"8-K","ticker":"BGLC","cik":"0001737523","company_name":"BioNexus Gene Lab Corp","filed_at":"2023-09-07T23:59:59+00:00","discovered_at":"2026-05-14T18:03:35.046177+00:00","generated_at":"2026-06-10T22:55:28.403971+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Bionexus Gene Lab COO Liong Tai Tan resigns; Lee Su-Leng Tan appointed COO","bullets":["Liong Tai Tan resigned as COO and director effective August 31, 2023; no disagreement with company.","Board approved Lee Su-Leng Tan as COO effective September 1, 2023; he is not a director.","Lee Su-Leng Tan, aged 40, has over 20 years of experience in life sciences, hospitality, and property.","New COO entered employment agreement dated August 15, 2023, with annual compensation of $24,000.","Tan previously served as Chief Commercial Officer at Dryox Health and Managing Director at Biotechnology Group."],"urls":{"canonical":"https://secwatch.observer/filing/0001477932-23-006695","json":"https://secwatch.observer/filing/0001477932-23-006695.json","markdown":"https://secwatch.observer/filing/0001477932-23-006695.md","text":"https://secwatch.observer/filing/0001477932-23-006695.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1737523/000147793223006695/0001477932-23-006695-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1737523/000147793223006695/bglc_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-10T22:55:28.403971+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"1c1da4ef9a","claim":"Liong Tai Tan resigned as Director at BioNexus Gene Lab Corp.","evidence_excerpt":"The Company and Mr. Liong Tai Tan agreed that the resignations would be effective August 31, 2023.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1737523/000147793223006695/0001477932-23-006695-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"},{"claim_id":"4f20864807","claim":"Lee Su-Leng Tan was appointed as Chief Operating Officer at BioNexus Gene Lab Corp.","evidence_excerpt":"the Board of Directors of the Company approved the appointment of Mr. Lee Su-Leng Tan as the Chief Operating Officer and not a director, effective September 1, 2023.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1737523/000147793223006695/0001477932-23-006695-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Chief Operating Officer"}],"fact_type":"executive_change"},{"claim_id":"c604dc7843","claim":"Liong Tai Tan resigned as Chief Operating Officer at BioNexus Gene Lab Corp.","evidence_excerpt":"Mr. Liong Tai Tan, the Chief Operating Officer and a member of the Board of Directors, notified Bionexus Gene Lab Corp. (“the Company”) of his desire to resign from his position at the Company.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1737523/000147793223006695/0001477932-23-006695-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"Chief Operating Officer"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}